Stock Code Company Long Name
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Annual Report 2012-13 Awards & Recognitions
Annual Report 2012-13 Awards & Recognitions SRF’s Chemicals Business wins Deming Prize The Chemicals Business of SRF won the coveted Deming Prize during the year. Roop Salotra, President & CEO, Chemicals Business received the medal and certificate from Hiromasa Yonekura, Chairman, Deming Prize Committee, at a ceremony held in Tokyo on November 14, 2012. Deming Prize is awarded by the Union of Japanese Scientists and Engineers (JUSE). Key Milestones…….2012-13 The Packaging Films Business bagged the Best SEZ Award within the ‘EPCES Export Award’ instituted by the Export Promotion Council for the 6th consecutive year SRF set up the firstHot Laminated Facility in the country to be able to expand its product range for Laminated Fabrics and compete at the higher end of the market SRF’s Coated Fabrics Business added new products such as Pagodas, Double Sided Striped Awnings and Lacquered Tarpaulins (printable) SRF’s Fluorochemicals Business introduced two new products – trichloroethylene and perchloroethylene SRF’s Chemical Technology Group filed7 new process patents as intellectual property of the company taking the total number to 29 SRF’s Engineering Plastics Business introduced Halogen free environmental friendly products for electrical segment and also made a significant headway in the international market SRF Foundation was conferred with the reputed 12th Businessworld FICCI CSR Award 2011-12 for its Kidsmart Early Learning Programme under the category of ‘Exemplary Innovation Promoting CSR’ Contents Chairman’s Message 02 Company Information 04 Corporate Overview Notice 06 Directors’ Report 10 Management Discussion and Analysis 20 Corporate Governance Report 28 Management Reports Standalone Financial Statements 40 Consolidated Financial Statements 87 Financial Statements Annual Report 2012-13 Chairman’s Message Dear shareholders, Let me begin by sharing with you some good news. -
Healthcare Sector in India Flanders Investment & Trade Market Survey
HEALTHCARE SECTOR IN INDIA FLANDERS INVESTMENT & TRADE MARKET SURVEY Healthcare Sector in India Flanders Investment & Trade Economic Representation of Flanders c/o Embassy of Belgium 50 - N, Shantipath, Chanakyapuri New Delhi - 110 021 India [email protected] T: +91 11 42 42 81 00 F: +91 11 42 42 81 10 Studie Healthcare Sector in India | juni 2015 1 2 TABLE OF CONTENTS ICT in Healthcare Services in India ................................................................................................. 8 Introduction ......................................................................................................................................... 8 Healthcare Information & Communication Technology (HICT) ...................................................... 9 Patient Monitoring & Tracking ........................................................................................................ 9 Healthcare Information Technology (HIT) ..................................................................................... 10 National Health Policy ................................................................................................................... 10 Health Information Management Systems (HIMS) ....................................................................... 10 Grading of Indian States for the use of ICT in Hospitals ................................................................ 12 Telemedicine .................................................................................................................................... -
Indiaghg-Aug15 0.Pdf
The India Greenhouse Gas (GHG) Program is a voluntary, industry-led partnership, focused on building institutional capabilities towards measuring and managing greenhouse gas emissions, based on the GHG Protocol WHO WE ARE The India GHG Program was launched in July 2013 by WRI India, The Energy and Resources Institute (TERI), and the Confederation of Indian Industry (CII), with support from India’s key businesses as founding member companies. Several progressive companies, including automotive, aviation, telecom, cement, chemicals, manufacturing, financial services, information technology, consumer, agri-business, textiles, and others are voluntary members of the Program. The total inventory managed by businesses under the India GHG Program ranges from 300 to 360 million TCO2e. This is equivalent to 15 to 25 percent of India’s total emissions. What climate change challenges does India face? While it is difficult to quantify the expected impact of climate change, a recent orldW Bank study indicates that countries like India will need USD 70 to 100 billion each year through 2050 to meet the current and future climate adaptation needs. However, our current spending is around USD 4.4 billion. The challenges, including water availability, changing rainfall patterns, resilience capabilities, disaster management, and others hold serious implications for communities, businesses, and for the country’s future growth and development. What role can the corporate sector play? Businesses are not only essential for continued economic growth, but they also have an immense opportunity in aiding large-scale reduction of emissions which can help mitigate the impacts of climate change. Approximately 38 percent of India’s greenhouse gas emissions come from energy generation and industrial and commercial users consume about 76 percent of that energy. -
FHL Annual Report 2020-21
ANNUAL REPORT 2020-2021 COMPANY INFORMATION CONTENTS BOARD OF DIRECTORS CORPORATE OVERVIEW CLINICAL EXCELLENCE Chairman 02 Introduction 66 Dedicated to Serve Responsibly Ravi Rajagopal (Independent Director) 04 Vision and Mission AWARDS AND ACCOLADES 06 Values Vice-Chairman 74 Inspired By Recognitions Shirish Moreshwar Apte (Non-Executive Director) 08 Key Performance Highlights 2020-21 HUMAN RESOURCES Managing Director and CEO BOARD OF DIRECTORS 78 Inspiring Trust Through the People Power Dr. Ashutosh Raghuvanshi 10 Fortis Healthcare Limited 12 SRL Limited Non-Executive Directors STATUTORY REPORTS Dilip Kadambi MANAGEMENT COMMUNIQUE 84 Director’s Report Dr. Farid Bin Mohamed Sani 136 Report on Corporate Governance 14 From the Chairman’s Desk Heng Joo Joe Sim 164 Business Responsibility Report Joerg Ayrle 18 MD & CEO’s Message (FHL) 175 Management Discussion and Analysis Report Dr. Kelvin Loh Chi-Keon 22 CEO’s Message (SRL) Takeshi Saito FINANCIAL STATEMENTS COVID-19 AND OUR RESPONSE Independent Directors 26 A Clear and Compelling Purpose 191 Standalone Financials Indrajit Banerjee 283 Consolidated Financials Shailaja Chandra FORTIS HEALTHCARE LIMITED Suvalaxmi Chakraborty 32 Inspiring Trust Across the Nation Chief Financial Officer OUR TRANSFORMATION Vivek Kumar Goyal 38 The New Journey Company Secretary and Compliance Officer FINANCIAL HIGHLIGHTS Sumit Goel 40 Performance Snapshot Auditors CLINICAL FOCUS B S R & Co. LLP Chartered Accountants 44 New Clinical Offerings Fortis Healthcare Limited 46 Speciality Mix CIN: L85110PB1996PLC045933 -
Big Power Trade - Futuros National Stock Exchange of India (NSE)
BiG Power Trade - Futuros National Stock Exchange of India (NSE) País / Região Bolsa Produto Horário Futuros (Moeda, National Stock Exchange of India (NSE) Segunda-feira - Sexta-feira: Acções, Índices de 9:15-15:30 IST* Índia www.nseindia.com acções) IB Simbolo Instrumento Simbolo Moeda ACC ACC LIMITED ACC INR ADANIPOWE ADANI POWER LIMITED ADANIPOWER INR AJANTPHAR AJANTA PHARMA LTD AJANTPHARM INR ALBK ALLAHABAD BANK ALBK INR AMARAJABA AMARA RAJA BATTERIES LTD AMARAJABAT INR AMBUJACEM AMBUJA CEMENTS LIMITED AMBUJACEM INR ANDHRABAN ANDHRA BANK ANDHRABANK INR APOLLOHOS APOLLO HOSPITALS ENTERPRISE APOLLOHOSP INR APOLLOTYR APOLLO TYRES LIMITED APOLLOTYRE INR ARVIND ARVIND LTD ARVIND INR ASHOKLEY ASHOK LEYLAND LIMITED ASHOKLEY INR ASIANPAIN ASIAN PAINTS LTD ASIANPAINT INR AUROPHARM AUROBINDO PHARMA LTD AUROPHARMA INR AXISBANK AXIS BANK LTD AXISBANK INR BAJAJ-AUT BAJAJ AUTO LIMITED BAJAJ-AUTO INR BAJAJFINS BAJAJ FINSERV LTD BAJAJFINSV INR BAJFINANC BAJAJ FINANCE LTD BAJFINANCE INR BALKRISIN BALKRISHNA INDUSTRIES LTD BALKRISIND INR BALRAMCHI BALRAMPUR CHINI MILLS LTD BALRAMCHIN INR BANKBAROD BANK OF BARODA BANKBARODA INR BANKINDIA BANK OF INDIA BANKINDIA INR BANKNIFTY Nifty Bank BANKNIFTY INR BATAINDIA BATA INDIA LTD BATAINDIA INR BEL BHARAT ELECTRONICS LTD BEL INR BEML BEML LIMITED BEML INR BERGEPAIN BERGER PAINTS INDIA LTD BERGEPAINT INR BHARATFIN BHARAT FINANCIAL INCLUSION L BHARATFIN INR BHARATFOR BHARAT FORGE LIMITED BHARATFORG INR BHARTIART BHARTI AIRTEL LIMITED BHARTIARTL INR BHEL BHARAT HEAVY ELECTRICALS BHEL INR BIOCON BIOCON LTD BIOCON -
Fortis Healthcare Limited
FORTIS HEALTHCARE LIMITED Earnings Presentation – Q2FY21 November 12, 2020 Disclaimer This presentation may not be copied, published, distributed or transmitted. The presentation has been prepared solely by the company. Any reference in this presentation to “Fortis Healthcare Limited” shall mean, collectively, the Company and its subsidiaries. This presentation has been prepared for informational purposes only. This presentation does not constitute a prospectus, offering circular or offering memorandum and is not an offer or invitation to buy or sell any securities, nor shall part, or all, of this presentation form the basis of, or be relied on in connection with, any contract or investment decision in relation to any securities. Furthermore, this presentation is not and should not be construed as an offer or a solicitation of an offer to buy securities of the company for sale in the United States, India or any other jurisdiction. Securities may not be offered or sold in the United States absent registration or an exemption from registration. Any public offering in the United States may be made only by means of an offering document that may be obtained from the Company and that will contain detailed information about the Company and its management, as well as financial statements. Any offer or sale of securities in a given jurisdiction is subject to the applicable laws of that jurisdiction. This presentation contains forward-looking statements based on the currently held beliefs and assumptions of the management of the Company, which are expressed in good faith and, in their opinion, reasonable. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance, or achievements of the Company or industry results, to differ materially from the results, financial condition, performance or achievements expressed or implied by such forward-looking statements. -
Fortis Healthcare Limited Investor Presentation – Q3 FY2013
Fortis Healthcare Limited Earnings Presentation – FY20 and Q4 FY20 June 17, 2020 Disclaimer This presentation may not be copied, published, distributed or transmitted. The presentation has been prepared solely by the company. Any reference in this presentation to “Fortis Healthcare Limited” shall mean, collectively, the Company and its subsidiaries. This presentation has been prepared for informational purposes only. This presentation does not constitute a prospectus, offering circular or offering memorandum and is not an offer or invitation to buy or sell any securities, nor shall part, or all, of this presentation form the basis of, or be relied on in connection with, any contract or investment decision in relation to any securities. Furthermore, this presentation is not and should not be construed as an offer or a solicitation of an offer to buy securities of the company for sale in the United States, India or any other jurisdiction. Securities may not be offered or sold in the United States absent registration or an exemption from registration. Any public offering in the United States may be made only by means of an offering document that may be obtained from the Company and that will contain detailed information about the Company and its management, as well as financial statements. Any offer or sale of securities in a given jurisdiction is subject to the applicable laws of that jurisdiction. This presentation contains forward-looking statements based on the currently held beliefs and assumptions of the management of the Company, which are expressed in good faith and, in their opinion, reasonable. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance, or achievements of the Company or industry results, to differ materially from the results, financial condition, performance or achievements expressed or implied by such forward-looking statements. -
Escorts Limited •• S~F2
c ESCORTS February 19, 2021 BSE Limited National Stock Exchange of Delhi Stock Exchange Limited Phiroze Jeejeebhoy India Limited DSE House, 3/1, Asaf Ali Road, Towers, Dalal Street, Exchange Plaza, Sandra New Delhi -110002 Mumbai - 400001 Kurla Complex, Bandra East, Mumbai - 400051 BSE-500495 NSE - ESCORTS DSE -00012 ••'*' Subject: Intimation pursuant to Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/ Madam, In compliance of Regulation 31A of Securities and Exchange Board of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has received the enclosed request letter cum undertaking dated February 19, 2021 from the following shareholders currently belonging to Promoter/ Promoter Group of the Company for their reclassification from category of 'Promoter/ Promoter Group' to 'Public': Name No. of Shares as on date Mr. Girish Behari Mathur- Promoter Group 179 Ms. Rachna Mathur - Promoter group I Person acting 75 in concert The Company would take necessary actions to give effect to the above request. ,, You are requested to take the same on record Thanking You, Yours faithfully, For Escorts Limited •• s~f2. Company Secretary & Compliance Officer Encl: As above ESCORTS LIMITED CorporatE1 Secretarial & Low Registered Office : 15/5, Mothura Rood, Foridobod - 121 003, Horyana, Indio Phone : +91-129-2250222, ' E·moil : [email protected], Website : www.escortsgroup.com Corporate Identification Number - L74899HR1944PLC039088 Date: February 19, 2021 To The Board of Directors Escorts limited 15/5, Mathura Road, Faridabad -121003, Haryana Dear Sir/ Madam, Sub: Removal of my name along with the Person acting in Concert from Promoter and Promoter Group shareholding of the Escorts Limited ("Company") Ref: Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) regulations, 2015 With reference to the above, I would like to inform that I, Girish Behari Mathur, along with my spouse Mrs. -
Vedanta Refer to Important Disclosures at the End of This Report
India Equity Research | Metals & Mining October 5, 2020 Result Update Vedanta Refer to important disclosures at the end of this report Q1 beats estimates; promoter entities dip in CIHL cash pool before delisting CMP: Rs 137 TP: Rs 170 (▲) Rating: BUY (■) Upside: 23.7 % as of (October 4, 2020) 12 months . Cairn India Holdings Ltd, a 100% subsidiary of Vedanta Ltd (Ved Ltd), has provided a loan Change in Estimates of Rs23.11bn to promoter entity Vedanta Resources (Ved Plc) which can extend up to EPS Chg FY21E/FY22E (%) -/ Rs79.05bn ($1.05bn) in loans and guarantees. Contours of the transaction are awaited. Target Price change (%) 33.9 . Ved Ltd is treating this loan as cash in its books, even though the money has been Target Period (Months) 12 transferred outside its books, which we believe is not the best way of accounting loans Previous Reco BUY given to parent. Emkay vs Consensus EPS Estimates . Management has reduced Rs42.76/sh of book value in Ved Ltd books through the write- off of a substantial portion of the O&G book despite Brent hovering around $43/bbl. But FY21E FY22E advance given to promoter entity KCM is treated as recoverable despite the appointment Emkay 5.7 18.2 of a provisional liquidator in KCM. Consensus 7.1 15.0 Mean Consensus TP (12M) Rs 148 . Maintain Buy with a revised TP of Rs170 as delisting price target as we remove the 30% holdCo discount which we applied in the past for the valuation of Ved Ltd as a listed entity Stock Details on SoTP basis. -
Overview of CESC - Kolkata Distribution Business
CESC Limited Powering India since 1899 1 This presentation has been prepared by and is the sole responsibility of CESC Limited (the “Company”). By accessing this presentation, you are agreeing to be bound by the trailing restrictions. This presentation does not constitute or form part of any offer or invitation or inducement to sell or issue, or any solicitation of any offer or recommendation to purchase or subscribe for, any securities of the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment therefor. In particular, this presentation is not intended to be a prospectus or offer document under the applicable laws of any jurisdiction, including India. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this presentation. There is no obligation to update, modify or amend this communication or to otherwise notify the recipient if information, opinion, projection, forecast or estimate set forth herein, changes or subsequently becomes inaccurate. Certain statements contained in this presentation that are not statements of historical fact constitute “forward-looking statements.” You can generally identify forward-looking statements by terminology such as “aim”, “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “intend”, “may”, “objective”, “goal”, “plan”, “potential”, “project”, “pursue”, “shall”, “should”, “will”, “would”, or other words or phrases of similar import. -
Annual Report (2018-2019)
73rd Annual Report 2018-19 Inside the Report Core divisions Key highlights FY 2018-19* Corporate Overview Revenue 2 Escorts at a Glance (H in crores) 4 Milestone Moments 6 Product Suite 6,196.4 8 Operational Highlights Escorts Agri Machinery 10 Key Performance Indicators (EAM) 23.5% Y-o-Y growth 12 From the Chairman’s Desk Offers a comprehensive range of advanced farm 16 Message from the Executive Director machinery products and crop 18 External Environment solution services, enriching EBITDA 22 Management Speak agricultural productivity in (H in crores) 24 Customer Centricity India and globally. 26 Excellence 76.6% 733.3 28 Innovation of Revenue 30 Agility 31.6% Y-o-Y growth 32 Board of Directors 34 Leadership Team 36 Social and Environment Sustainability Profit after tax (H in crores) Statutory Reports 38 Management Discussion and Analysis Escorts Construction 484.9 48 Directors’ Report Equipment (ECE) addresses India’s diverse 40.7% 63 Report on Corporate Governance Y-o-Y growth infrastructure requirements 98 Business Responsibility Report with a wide basket of material handling, road building, Financial Statements earth moving and other Earnings 108 Standalone Financial Statements equipment services. per share (H) 186 Consolidated Financial Statements 17.0% of Revenue About Escorts 40.58 40.7% Escorts Limited (Escorts) is one Y-o-Y growth of India’s leading engineering conglomerates. We manufacture best-in-class equipment for agriculture, *Standalone Financials infrastructure and railways. Ever since inception, we have played an important role in helping shape the country’s socio-economic progress. Railway Equipment Division (RED) Across three core businesses in plays a key role in the which we operate, we are pursuing evolution of the Indian innovation, fostering collaborations, Railway, with frugally driving modernisation and implementing engineered products, advanced manufacturing practices, cutting-edge technology to bring the best that the world has and state-of-the-art Research to offer to India; and take India’s best and Development (R&D). -
BENCHMARK: Nifty Midcap
EMERGING LEADERS EQUITY FUND The objective of this fund is to generate capital appreciation in the long term through investments predominantly in mid cap stocks BENCHMARK: Nifty Midcap 100 Fund Performance as on 31st August 2021 Fund Benchmark 80% 73.7% 70.3% DATE OF INCEPTION 70% 60% TH 26 FEBRUARY 2018 50% 40% 35.9% 34.6% 30% 24.5% 22.1% 20% 15.4% 13.4% 12.6% 10.7% 10% 2.6% 2.2% 0% TOTAL Inception 3 yrs 2 yrs 1 yr 6 M 1 M 0% - 40% 100.0% 224.9 Emerging Leaders Equity Fund benchmark is Nifty Midcap 100 Money Market Actual AUM^ IN Modified Duration of Debt and Money Market: 0.00 years Allocation Rs. Crore Instruments and Past performance is not indicative of future performance Others 60% - 100% The SFIN for Emerging Leaders Equity Fund is ULIF02020/12/17EMLEDEQFND136 The Benchmark of the fund has been changed from Nifty Midcap 50 to Nifty Midcap 1.1% 2.6 Equity and Equity ^Assets Under Management 100 with effect from 1st January 2021. The Benchmark performance given above for Actual AUM^ IN Related Instruments Allocation Rs. Crore all tenures is as per Nifty Midcap 100. 98.9% 235.9 NAV as on 31st August 2021: Rs. 15.5667 Actual AUM^ IN Allocation Rs. Crore TOP 10 HOLDING AS ON 31ST AUGUST 2021 % Equity 98.9 SRF Limited 2.3 Shriram Transport Finance Company Limited 2.1 Cholamandalam Investment and Finance Company Limited 2.1 TOP 10 INDUSTRY SECTOR EXPOSURE (%) Crompton Greaves Consumer Electricals Limited 2.0 37.9 40 Laurus Labs Ltd 2.0 35 AU Small Finance Bank Limited 2.0 Bharat Forge Limited 2.0 30 Mphasis Limited 1.9 25 Mindtree Limited